Trinity Biotech plc (ADR) (NASDAQ:TRIB)
CAPS Rating:
The Company develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market.
The Company develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market.
Recs
It's a BS company